Skip to content

Comparison of the Effects of Calcium, Vitamin D, and Calcium plus Vitamin D On Anthropometric Indices, Body Composition, Lipid Profile, Blood Pressure, and Blood Glucose in Overweight or Obese Premenopausal women.

Comparison of the Effects of Calcium, Vitamin D, and Calcium plus Vitamin D On Anthropometric Indices, Body Composition, Lipid Profile, Blood Pressure, and Blood Glucose in Overweight or Obese Premenopausal women.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014021116555N1
Enrollment
100
Registered
2014-05-18
Start date
2014-05-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

overweight and obesity. Obesity due to excess calories

Interventions

Intervention 1: 2 tablet of placebo with low calorie diet. Intervention 2: 2 tablet of calcium (500 mg calcium carbonate /tablet) with low calorie diet. Intervention 3: 2 tablet of calcium plus vitami
Placebo
Treatment - Drugs
2 tablet of placebo with low calorie diet
2 tablet of calcium (500 mg calcium carbonate /tablet) with low calorie diet
2 tablet of calcium plus vitamin D (500 mg calcium carbonate and 200 IU vitamin D / tablet) with low calorie diet
2 tablet of vitamin D (200 IU vitamin D / tablet) with low calorie diet

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: premenopausal women; age between 20-50 years; BMI between 25-40 kg/m2; not having any cancer or severe endocrine, mental, hepatic, renal, gastrointestinal, cardiovascular, neurologic, rheumatologic, hematologic, skeletal, and eating disorders; not taking any medication, nutritional supplements, or herbal preparations that could affect calcium and vitamin D status, anthropometric indices, body composition, lipid profile, blood pressure, and blood glucose during the last 12 weeks; not having any history of drug intolerance or adverse reaction to the study supplements; Dairy product consumption of =3 serving /d; consumption of =5 cups of coffee/d; not being pregnant or lactating; not being a smoker or taking alcohol; not being a participant in other trials over the last 6 months; Stable body weight (body weight change?3 kg for 3mo before intervention); providing written informed consent. exclusion criteria: development of serious adverse events during the study period and lack of adherence to the study protocol.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Waist circumference. Timepoint: At the beginning and at the end of the intervention. Method of measurement: Tape measure.;Body mass index. Timepoint: At the beginning and at the end of the study. Method of measurement: BMI will be calculated as weight (kg)/ height (m)2.;Body fat mass. Timepoint: At the beginning and at the end of the intervention. Method of measurement: Bioelectric impedance analyzer.;Lipid profile. Timepoint: At the beginning and at the end of the intervention. Method of measurement: By use of bt 1500 set and pars test kit.;Blood pressure. Timepoint: At the beginnig and at the end f the intervention. Method of measurement: mmHg-piezometer.;Blood glucose. Timepoint: At the beginnig and at the end f the study. Method of measurement: by Autoanalyzer method using Pars test kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamide Rajaie

School of Nutrition and Food Sciences

hamiderajaie@yahoo.com+98 71 1725 1001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026